 |
|
 |
Advisory Committee on Immunization Practices |
|
| FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION |
|
ACIP Recommendations: 2012 |
|
|
| |
|
|
|
|
ACIP Provisional
Recommendations Prevention of Measles, Rubella, Congenital
Rubella Syndrome (CRS), and Mumps
Source: Centers for Disease Control and Prevention, December
6, 2012 |
|
|
HTML | PDF |
Use of 13-Valent Pneumococcal
Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide
Vaccine for Adults with Immunocompromising Conditions:
Recommendations of the Advisory Committee on Immunization
Practices (ACIP)
Source: MMWR, October 12,
2012; 61(40):816-9 |
|
|
HTML | PDF |
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)United States, 201213
Influenza Season
Source: MMWR, August 18, 2012;61(32);613-8 |
|
|
HTML | PDF |
Updated CDC Recommendations
for the Management of Hepatitis B VirusInfected Health-Care
Providers and Students
(Not an ACIP statement
but an important document from CDC.)
Source: MMWR, July 6,
2012; 61(RR03):1-12 |
|
|
HTML | PDF |
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine
in Adults Aged 65 Years and Older Advisory Committee on Immunization Practices (ACIP), 2012
Source: MMWR, June 29, 2012; 61(25):468-70 |
|
|
HTML | PDF |
Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
Source: MMWR, June 1, 2012; 61(21):394-5 |
|
|
HTML | PDF |
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years - United States, 2012
Source: MMWR, February 10, 2012; 61(5):1-4 |
|
|
HTML | PDF |
Recommended Adult
Immunization Schedule United States, 2012
Source: MMWR, February 3, 2012; 61(4):1-7
|
|
HTML | PDF |
|
|
| This
page was reviewed on February 21, 2013 |
|
 |
|
|
|
|
|
Immunization Action Coalition • 1573 Selby Ave • St. Paul, MN 55104 |
|
tel 651-647-9009 • fax 651-647-9131 |
|
|
| |
|
|
|
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC. |
|
|
| |
| |
|
|
| |
|